Parkinson Disease Clinical Trials in Spokane, Washington

3 studies are recruiting for parkinson disease in Spokane, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Inland Northwest Research, Spokane, Washington
    Locations
    72 in total
    Run by
    Neuron23 Inc.

    See if you can join NCT06680830 on ClinicalTrials.gov

  2. Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

    A phase 2a multicenter, randomized, double-blind, placebo-controlled multiple dose study to evaluate the safety, tolerability, pharmacokinetics, of HBI-002, an oral low-dose carbon monoxide (CO) liquid drug product, administered daily over 14 days in subjects with Parkinson's disease (PD).

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Inland Northwest Research, Spokane, Washington
    Locations
    5 in total
    Run by
    Hillhurst Biopharmaceuticals, Inc.

    See if you can join NCT07005180 on ClinicalTrials.gov

  3. A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

    The purpose of this study is to generate evidence of the safety, tolerability, and pharmacokinetics/pharmacodynamics of IV LY4006896 compared with placebo in healthy participants and participants with Parkinson's disease.

    Stage
    Phase 1
    Ages
    30 to 85
    Site
    Inland Northwest Research, Spokane, Washington
    Locations
    14 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06809400 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.